These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

851 related items for PubMed ID: 15457847

  • 1. Placental site trophoblastic tumor: an overview.
    Bonazzi C, Urso M, Dell'Anna T, Sacco S, Buda A, Cantú MG.
    J Reprod Med; 2004 Aug; 49(8):585-8. PubMed ID: 15457847
    [Abstract] [Full Text] [Related]

  • 2. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
    Lurain JR, Singh DK, Schink JC.
    J Reprod Med; 2006 Oct; 51(10):767-72. PubMed ID: 17086804
    [Abstract] [Full Text] [Related]

  • 3. Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic, high-risk gestational trophoblastic disease.
    Schink JC, Singh DK, Rademaker AW, Miller DS, Lurain JR.
    Obstet Gynecol; 1992 Nov; 80(5):817-20. PubMed ID: 1328977
    [Abstract] [Full Text] [Related]

  • 4. Management of resistant gestational trophoblastic tumors.
    Newlands ES, Bower M, Holden L, Short D, Seckl MJ, Rustin GJ, Begent RH, Bagshawe KD.
    J Reprod Med; 1998 Feb; 43(2):111-8. PubMed ID: 9513872
    [Abstract] [Full Text] [Related]

  • 5. Secondary chemotherapy for high-risk gestational trophoblastic neoplasia.
    Lurain JR, Nejad B.
    Gynecol Oncol; 2005 May; 97(2):618-23. PubMed ID: 15863169
    [Abstract] [Full Text] [Related]

  • 6. Prolonged remission of recurrent, metastatic placental site trophoblastic tumor after chemotherapy.
    Randall TC, Coukos G, Wheeler JE, Rubin SC.
    Gynecol Oncol; 2000 Jan; 76(1):115-7. PubMed ID: 10620452
    [Abstract] [Full Text] [Related]

  • 7. Placental site trophoblastic tumor: a review of 7 cases and their implications for prognosis and treatment.
    Hoekstra AV, Keh P, Lurain JR.
    J Reprod Med; 2004 Jun; 49(6):447-52. PubMed ID: 15283052
    [Abstract] [Full Text] [Related]

  • 8. Role of surgery in the management of high-risk gestational trophoblastic neoplasia.
    Lurain JR, Singh DK, Schink JC.
    J Reprod Med; 2006 Oct; 51(10):773-6. PubMed ID: 17086805
    [Abstract] [Full Text] [Related]

  • 9. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
    Newlands ES, Mulholland PJ, Holden L, Seckl MJ, Rustin GJ.
    J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
    [Abstract] [Full Text] [Related]

  • 10. Placental site trophoblastic tumour: clinical features and management.
    Hassadia A, Gillespie A, Tidy J, Everard R G N J, Wells M, Coleman R, Hancock B.
    Gynecol Oncol; 2005 Dec; 99(3):603-7. PubMed ID: 16085293
    [Abstract] [Full Text] [Related]

  • 11. Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease.
    Soper JT, Evans AC, Clarke-Pearson DL, Berchuck A, Rodriguez G, Hammond CB.
    Obstet Gynecol; 1994 Jan; 83(1):113-7. PubMed ID: 8272290
    [Abstract] [Full Text] [Related]

  • 12. Management of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine chemotherapy.
    Cyriac S, Rajendranath R, Sridevi V, Sagar TG.
    J Reprod Med; 2011 Jan; 56(5-6):219-23. PubMed ID: 21682117
    [Abstract] [Full Text] [Related]

  • 13. Pregnancy after EMA/CO for gestational trophoblastic disease: a report from The Netherlands.
    Lok CA, van der Houwen C, ten Kate-Booij MJ, van Eijkeren MA, Ansink AC.
    BJOG; 2003 Jun; 110(6):560-6. PubMed ID: 12798472
    [Abstract] [Full Text] [Related]

  • 14. Management of brain metastases in patients with high-risk gestational trophoblastic tumors.
    Newlands ES, Holden L, Seckl MJ, McNeish I, Strickland S, Rustin GJ.
    J Reprod Med; 2002 Jun; 47(6):465-71. PubMed ID: 12092015
    [Abstract] [Full Text] [Related]

  • 15. Management of drug resistant gestational trophoblastic neoplasia.
    Patel SM, Desai A.
    J Reprod Med; 2010 Jun; 55(7-8):296-300. PubMed ID: 20795341
    [Abstract] [Full Text] [Related]

  • 16. High-risk metastatic gestational trophoblastic tumors. Current management.
    Lurain JR.
    J Reprod Med; 1994 Mar; 39(3):217-22. PubMed ID: 7518518
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of patients with trophoblastic tumors in the Academic Medical Center: 31 patients in 10 years, 1983-1992].
    Laan R, Bakker P, Lammes FB.
    Ned Tijdschr Geneeskd; 1995 Sep 09; 139(36):1829-34. PubMed ID: 7477506
    [Abstract] [Full Text] [Related]

  • 18. Treatment of high-risk gestational trophoblastic disease with methotrexate, actinomycin D, and cyclophosphamide chemotherapy.
    Lurain JR, Brewer JI.
    Obstet Gynecol; 1985 Jun 09; 65(6):830-6. PubMed ID: 2987766
    [Abstract] [Full Text] [Related]

  • 19. Twenty-five years' clinical experience with placental site trophoblastic tumors.
    Papadopoulos AJ, Foskett M, Seckl MJ, McNeish I, Paradinas FJ, Rees H, Newlands ES.
    J Reprod Med; 2002 Jun 09; 47(6):460-4. PubMed ID: 12092014
    [Abstract] [Full Text] [Related]

  • 20. Management of gestational trophoblastic neoplasia with metastasis to the central nervous system: A 12-year review at the Philippine General Hospital.
    Cagayan MS, Lu-Lasala LR.
    J Reprod Med; 2006 Oct 09; 51(10):785-92. PubMed ID: 17086807
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.